SU-E-T-239: In Vivo Dosimetry with Surface Diodes during Total Body Irradiation: A Patient Thickness Factor to Correct Midline Dose.
In vivo dosimetry (IVD) assessment of treatment dose is important when delivering total body irradiation (TBI). One method is to average AP and PA surface diode measurements and compare them to prescribed midline doses. We designed phantom studies to examine the impact of patient thickness on surface IVD measurements under TBI conditions. Phantom studies were designed to assess the effects of patient thickness on diode IVD. Sun Nuclear QED diodes with inherent buildup were placed on anterior and posterior surfaces of a solid water phantom. Phantom thickness was varied between 20 and 40 cm. A PTW farmer chamber was inserted in the center of the phantom at 425 SSD to reflect prescribed midline dose, and 50 cGy was delivered to midline with 18 MV photons. Averaged entrance and exit diode doses were then compared to farmer chamber measurements of phantom midline dose. A trend of increased deviation with increasing umbilicus thickness was observed between averaged surface diodes and midline farmer chamber measurements. Averaged surface diode dose ranged from 49.6 cGy (20 cm thickness) to 52.1 cGy (40 cm thickness). Interpolation of diode measurements to midline resulted in linear overestimation of delivered dose relative to farmer chamber measurements at midline, up to 6.8% at 40 cm umbilicus thickness. Accurate in vivo dosimetry at time of patient TBI is important to allow individual correction of MU exposure and tissue compensation. Without patient thickness correction, overresponse of surface diodes may lead to unnecessary clinical intervention to treatment MU or compensation and insufficient midline dose. Additionally, SAD setup is preferable to SSD setup to minimize thickness non-linearity. In conclusion, thickness correction factors should be used to generate expected diode readings for patients with thickness greater than 30 cm.